- Recommendation ID
- NG202/2
- Question
What is the clinical and cost effectiveness of auto- and fixed-level continuous positive airway pressure (CPAP) for managing moderate and severe OSAHS?
- Any explanatory notes
(if applicable) For a short explanation of why the committee made the recommendation for research, see the rationale section on treatments for moderate and severe OSAHS .
Full details of the evidence and the committee's discussion are in evidence review F: positive airway pressure therapy variants for OSAHS, OHS and COPD–OSAHS overlap syndrome.
Source guidance details
- Comes from guidance
- Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16s
- Number
- NG202
- Date issued
- August 2021
Other details
| Is this a recommendation for the use of a technology only in the context of research? | No |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |
| Last Reviewed | 31/08/2021 |